Skip to main content
All lobbying filings

COLLEGE OF AMERICAN PATHOLOGISTS

Lobbying for COLLEGE OF AMERICAN PATHOLOGISTS

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $124,816.00 expenses · posted Oct 17, 2025

Official filing document

 Bills named in this filing 56
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 2433
    Reducing Medically Unnecessary Delays in Care Act of 2025
  • S 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • S 998
    Medical Supply Chain Resiliency Act
  • HR 539
    Chiropractic Medicare Coverage Modernization Act of 2025
  • HR 2483
    SUPPORT for Patients and Communities Reauthorization Act of 2025
  • HR 2484
    Seniors’ Access to Critical Medications Act of 2025
  • HR 3580
    Oversight of Medicare Billing Code Cost Act
  • HR 977
    Support Military Families Act
  • HR 3561
    FORCE Act
  • HR 6025
    Appraisal Industry Improvement Act
  • S 709
    Conrad State 30 and Physician Access Reauthorization Act
  • HR 1585
    Conrad State 30 and Physician Access Reauthorization Act
  • S 1380
    SPARC Act
  • S 942
    REDI Act
  • HR 2028
    REDI Act
  • HR 879
    Medicare Patient Access and Practice Stabilization Act of 2025
  • HR 1463
    To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administrat…
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • HR 1201
    Doctors in our Borders Act
  • S 2439
    Resident Physician Shortage Reduction Act of 2025
  • HR 4731
    Resident Physician Shortage Reduction Act of 2025
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • HR 4710
    No Surprises Act Enforcement Act
  • HR 5582
    Patients Deserve Price Tags Act
  • S 2761
    RESULTS Act
  • HR 5269
    RESULTS Act
  • HR 9474
    Patent Eligibility Restoration Act of 2024
  • HR 9747
    Continuing Appropriations and Extensions Act, 2025
  • HR 10073
    Medicare Patient Access and Practice Stabilization Act of 2024
  • HR 9572
    Enhanced Enforcement of Health Coverage Act
  • HR 4875
    Doctors in our Borders Act
  • S 4935
    Physician Fee Stabilization Act
  • S 1916
    Protecting the Right To Keep and Bear Arms Act of 2021
  • HR 2389
    Resident Physician Shortage Reduction Act of 2023
  • HR 4942
    Conrad State 30 and Physician Access Reauthorization Act
  • HR 2377
    Saving Access to Laboratory Services Act
  • HR 1202
    REDI Act
  • HR 2761
    SPARC Act
  • HR 2764
    Green New Deal for Health Act
  • HR 3248
    Diagnostic Lab Testing Transparency Act
  • HR 4527
    Health DATA Act of 2023
  • HR 2474
    Strengthening Medicare for Patients and Providers Act
  • HR 6683
    Preserving Seniors’ Access to Physicians Act of 2023
  • S 3018
    Improving Seniors’ Timely Access to Care Act of 2021
  • HR 3173
    Improving Seniors’ Timely Access to Care Act of 2022
  • HR 6371
    Provider Reimbursement Stability Act of 2023
  • HR 2369
    VALID Act of 2023
  • S 2140
    Patent Eligibility Restoration Act of 2023
  • S 1451
    Healthy Competition for Better Care Act
  • HR 3120
    Healthy Competition for Better Care Act
  • S 3211
    Healthcare Workforce Resilience Act
  • HR 5392
    Timely Access to Coverage Decisions Act of 2023
  • S 4338
    Pay PCPs Act of 2024
 Lobbying activity 2
Health Issues

H.R. 1, the One Big, Beautiful Bill Act H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025 Improving seniors' timely access to care act (S. 1816 / H.R. 3514) Genomic Data Protection Act Tariffs S. 998, Medical Supply Chain Resiliency Act S 106 / HR 539 - Chiropractic Medicare Coverage Modernization Act PAMA reform HR 2483, Support for Patients and Communities Reauth Act HR 2484, Seniors access to Critical medications act Reducing Hereditary Cancer Act S 1399, the Health Tech Investment Act H.R. 3580, the Oversight of Medicare Billing Code Cost Act S 1830 - the Right to Treat Act S 1811 - Prohibits Graduate medical schools from receiving Federal assistance if DEI policies are in place S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine S 2066, Medicare transaction Fraud prevention act LCD legislation S 1866 - National Breast and Cervical Cancer Early Detection Program S 1882 - to expand research and training on reproductive health conditions HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR2761/S 705 - SPARC Act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act Continuing Appropriations Act, 2024 and Other Extensions Act Further Continuing Appropriations and Other Extensions Act, 2024 HR 6683 - Preserving Seniors Access to Physicians Act of 2023 Gene Therapy Precision Medicine Answers for Kids Today Act S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021 Dr. Lorna Breen Health Care Provider Protection Act PREVAIL HR 6371 - budget neutrality bill EDUCATE Act - Murphy DEI Bill HR 2369 - VALID Act FDA final rule on LDTs Pandemic All-Hazards Preparedness Act H.R.9747, the Continuing Appropriations and Extensions Act, 2025 S.2140/H.R. 9474, the Patent Eligibility Restoration Act of 2023 S.1451 / H.R. 3120 - Healthy Competition for Better Care Act H.R. 9572 - Enhanced Enforcement of Health Coverage Act H.R. 6025/S. 3211 - Healthcare Workforce Resilience Act Cures 2.1 H.R. 10073, Medicare patient Access and Practice Stabilization Act of 2024 S. 4935, Physician Fee Stabilization Act H.R. 5392, The Timely Access to Coverage Decisions Act of 2023 Medical Lab Personnel Shortage Relief Act H.R. 9572 Enhanced Enforcement of Health Coverage Act Sickle Cell Disease Comprehensive Care Act S. 709/H.R. 1585 - Conrad State 30 and Physician Access Reauthorization Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 H.R. 1463 - To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. H.R. 1968 - Continuing Resolution H.R. 1201 - Doctors in our Borders Act Issues relating to regulation of laboratory diagnostics Patent Eligibility Restoration Act CDC Division of Cancer Prevention and Control and cancer registries appropriations S. 2439 and H.R. 4731, Resident Physician Shortage Reduction Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 HR 3164 - Ensuring Community Access to Pharmacy Services Act (ECAPS) S 2800 - Pharmacy and Medically Underserved Areas Enhancement Act S 2420 / H.R. 4710 - No Surprises Act Enforcement Act S 2793 - Ensuring Access to Essential Providers Act of 2025 H.R. 5582 / S 2355 - Patients Deserve Price Tags Act Issues related to tariffs Issues related to public health

Medicare/Medicaid

FY 2026 Appropriations Student VISA issues Price Tags / Transparency Legislation CDC funding NIH Funding CLIAC reinstatement Issues relating to surprise medical bills Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Advocating for relief from cuts to evaluation and management codes within Medicare Issues relating to the debt limit Issues relating to site-neutral payments Issue relating to artificial intelligence Issues relating to combatting fentanyl crisis Issues relating to Medicare coverage pathways Researching Long Covid Fees paid on electronically submitting to insurers Issues relating to the Clinical Laboratory Fee Schedule Issues relating to forensic pathologist loan repayment Funding for the CDC AMD program Funding for lab test harmonization Issues surrounding Health Data Privacy Issues surrounding the Change Healthcare Cyber Attack Medicare payment reform S.4338 - Pay PCPs Act of 2024 Challenges facing independent medicine PTAC Reform Issues relating to blood donations Issues relating to the local coverage determination process Issues relating to GME Issues relating to laboratory accreditation procedures of IVF centers Issues relating to site neutral payment reform Issues relating to Medicaid funding S. 2761 and H.R. 5269, the RESULTS Act Issues related to cancer Issues related to the Medicare Access and CHIP Reauthorization Act of 2015

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem